Essential thrombocythemia with portal vein thrombosis and splenic infarction successfully treated with platelet apheresis
- 20 September 2021
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (9) , e245267
Abstract
A 63-year-old diabetic woman presented to the outpatient clinic with a 1-week history of abdominal pain. On complete evaluation, she was diagnosed to have essential thrombocythemia. Abdominal imaging revealed portal vein thrombosis with a large splenic infarct. The patient was started on anticoagulant, antiplatelet and cytoreductive therapy. In view of persistent high platelet count, plasma apheresis was done, following which the patient’s platelet counts were reduced. Essential thrombocythemia has a high rate of complications, resulting in significant morbidity and mortality. Few cases of this disease and its treatment have been described in the literature, especially pertaining to the Indian scenario. Further studies are needed to establish a multidisciplinary algorithm for its diagnosis and to elucidate the guidelines for the successful treatment of the condition.Keywords
This publication has 12 references indexed in Scilit:
- Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case ReportCase Reports in Oncology, 2020
- Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk‐stratification and managementAmerican Journal of Hematology, 2018
- The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based reviewLeukemia Research, 2017
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special IssueJournal of Clinical Apheresis, 2016
- Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET‐thrombosis) in 585 Mayo clinic patientsAmerican Journal of Hematology, 2016
- Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with budd-chiari syndrome and/or portal vein thrombosisTurkish Journal of Gastroenterology, 2015
- A latent form of essential thrombocythemia presenting asportal cavernomaWorld Journal of Gastroenterology, 2009
- Portal vein thrombosis as the first sign of a primary myeloproliferative disorder: diagnostic interest of the V617F JAK-2 mutation. A report of 2 cases.2008
- Evidence for rapid rapid mobilization of platelets from the spleen during intensive plateletpheresisAmerican Journal of Hematology, 1985
- Therapeutic Plateletpheresis in ThombocythemiaTransfusion, 1979